Clinical Trials, Drug Manufacturers

About the eMDI

By H&T Presspart

H&T Presspart and Cohero Health are currently collaborating with pharmaceutical manufacturers who are leveraging the technology for pipeline development and value-added product differentiation. As a fully functioning, market-ready device, it will enable pharmaceutical manufacturers to bring the best possible care to patients with asthma and COPD in the fastest time, and in the most cost-efficient way. Download this free white paper to find out more.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.